Skip to main content
. 2023 Aug 7;23:287. doi: 10.1186/s12890-023-02580-8

Table 1.

Patient characteristics in the derivation and validation set

Derivation set (n = 2555) Validation set (n = 685) P Value
Age, years, No. (%) 68 (61—77) 68 (60—77) 0.58
Sex, male, No. (%) 1182 (46.3%) 312 (45.5%) 0.77
PE severity grade, No. (%)
 Severe 353 (13.8%) 88 (12.8%) 0.79
 Moderate 140 (5.5%) 38 (5.5%)
 Mild 93 (3.6%) 21 (3.1%)
 No PE 1969 (77.1%) 538 (78.5%)
Symptoms, No. (%)
 Anhelation 671 (26.3%) 186 (27.2%) 0.67
 Lower limb edema 81 (3.2%) 31 (4.5%) 0.11
 Chest distress 840 (32.9%) 214 (31.2%) 0.44
 Chest pain 764 (29.9%) 210 (30.7%) 0.74
 Hemoptysis 35 (1.4%) 9 (1.3%)  > 0.99
 Syncope 188 (7.4%) 53 (7.7%) 0.80
 Cough 60 (2.3%) 20 (2.9%) 0.47
 Palpitation 248 (9.7%) 68 (9.9%) 0.92
Signs, median (IQR)
 Temperature, ℃ 36.5 (36.2—36.8) 36.5 (36.2—36.7) 0.30
 Heart rate, beats/min 88 (77—103) 88 (76—102) 0.91
 Systolic blood pressure, mmHg 140 (122—158) 139 (120—156) 0.82
 Diastolic blood pressure, mmHg 76 (66—86) 76 (67—86) 0.70
 Oxygen saturation, % 96 (94—98) 96 (94—98) 0.67
Past medical history, No. (%)
 Cancer 86 (3.4%) 32 (4.7%) 0.13
 Pulmonary embolism 61 (2.4%) 21 (3.1%) 0.39
 Immobilization 584 (22.9%) 144 (21.0%) 0.33
 Hypertension 423 (16.6%) 102 (14.9%) 0.15

Data are n (%), median (IQR), or mean (SD). Patients were randomly divided into the derivation and validation set using a stratified randomization scheme. P values were obtained using student t test for normally distributed variables, Wilcoxon rank sum test for skewed distributed variables and Chi-square (or Fisher’s exact) test for categorical variables